Researchers turn pain perception on and off in mice using light

February 18, 2014 by Bob Yirka, Medical Xpress report
Intrasciatic injection of AAV6-hSyn-ChR2-eYFP results in transduction of unmyelinated nociceptors projecting to spinal cord lamina I/IIo. Credit: Nature Biotechnology (2014) doi:10.1038/nbt.2834

(Medical Xpress)—A team of researchers at Stanford University has found a way to turn the perception of pain on and off using only a light source. In their paper published in the journal Nature Biotechnology, the team describes how they genetically altered nerve receptors beneath the skin in mice, and how doing so allowed for controlling the perception of pain.

Optogenetics, the science of using a to control cell functions, was first pioneered a decade ago in a lab co-run by Karl Deisseroth. He's now one of the co-founders of Circuit Therapeutics, a San Francisco-based research lab. There, he and colleagues are working to find a ways to use optogenetics to ease the various forms of that people experience. The idea is to genetically modify cells so that they respond in desired ways when light is shone on them. In this latest effort, the researchers did just that.

The team caused nerve cells just beneath the skin of several to respond to light—receptors were turned on or off—by first injecting a solution of molecules directly into the . The skin on mice feet is so thin that light can pass right through it and on to the below. Next, the team tested how well their solution worked by shining a light up at them through the floor of their cage. The mice flinched, cried out and licked their feet—all clear signs of pain. After that, the team attached tight bands to the paws of the treated mice, which normally causes pain, and then shone a different colored light onto them. This time, the treatment had the opposite effect—the mice appeared to be oblivious to the pain the bands were supposed to be causing. Thus, by shining two different colored lights on the impacted area, the researchers were able to turn pain perception on and off at will.

The researchers aren't suggesting that humans be injected with such chemicals any time soon. The whole point is to learn more about how light can be used to control cell activity and so that some new approach in the future can be used to help alleviate pain—the leading cause of doctor visits. The team notes that few good remedies now exist. Pills can help, but they can muddle the mind, cause constipation and lead to addiction. A simple hand-held flashlight device that allows a person to turn off pain at will would be a marked improvement.

Explore further: Research team identifies gene mutation that causes loss of pain perception

More information: Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice, Nature Biotechnology (2014) DOI: 10.1038/nbt.2834

Primary nociceptors are the first neurons involved in the complex processing system that regulates normal and pathological pain1. Because of constraints on pharmacological and electrical stimulation, noninvasive excitation and inhibition of these neurons in freely moving nontransgenic animals has not been possible. Here we use an optogenetic2 strategy to bidirectionally control nociceptors of nontransgenic mice. Intrasciatic nerve injection of adeno-associated viruses encoding an excitatory opsin enabled light-inducible stimulation of acute pain, place aversion and optogenetically mediated reductions in withdrawal thresholds to mechanical and thermal stimuli. In contrast, viral delivery of an inhibitory opsin enabled light-inducible inhibition of acute pain perception, and reversed mechanical allodynia and thermal hyperalgesia in a model of neuropathic pain. Light was delivered transdermally, allowing these behaviors to be induced in freely moving animals. This approach may have utility in basic and translational pain research, and enable rapid drug screening and testing of newly engineered opsins.

Related Stories

Research team identifies gene mutation that causes loss of pain perception

September 16, 2013
(Medical Xpress)—A large team of European researchers has identified a gene mutation that is responsible for causing a condition that leads to an inability to experience pain in humans. In their paper published in Nature ...

Putting the brakes on pain

August 5, 2013
Neuropathic pain—pain that results from a malfunction in the nervous system—is a daily reality for millions of Americans. Unlike normal pain, it doesn't go away after the stimulus that provoked it ends, and it also behaves ...

Brain uses serotonin to perpetuate chronic pain signals in local nerves

January 23, 2014
Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. ...

Recommended for you

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.